Review: A20‐Binding Inhibitor of NF‐κB Activation 1 Is a Physiologic Inhibitor of NF‐κB: A Molecular Switch for Inflammation and Autoimmunity

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2292-2302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 1, 2015-01 ,pp. : 177-186

Spandidos Publications

Access to resources Recommend Favorite

Overexpression of the human glucocorticoid receptor α and β isoforms inhibits AP-1 and NF-κB activities hormone independently

By Gougat Claire   Jaffuel Dany   Gagliardo Rosalia   Henriquet Corinne   Bousquet Jean   Demoly Pascal   Mathieu Marc  

Journal of Molecular Medicine, Vol. 80, Iss. 5, 2002-05 ,pp. : 309-318

Springer Publishing Company

Access to resources Recommend Favorite

NF‐κB1, NF‐κB2 and c‐Rel differentially regulate susceptibility to colitis‐associated adenoma development in C57BL/6 mice

By  

THE JOURNAL OF PATHOLOGY, Vol. 236, Iss. 3, 2015-07 ,pp. : 326-336

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigallocatechin‐3‐Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF‐κB and Nrf2/HO‐1 Signalling Pathway Regulation

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 3, 2015-09 ,pp. : 164-172

John Wiley & Sons Inc

Access to resources Recommend Favorite